Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Chan, Arlene Delaloge, Suzette Holmes, Frankie A Moy, Beverly Iwata, Hiroji Harvey, Vernon J Robert, Nicholas J Silovski, Tajana Gokmen, Erhan von Minckwitz, Gunter Ejlertsen, Bent Chia, Stephen K L Mansi, Janine Barrios, Carlos H Gnant, Michael Buyse, Marc Gore, Ira Smith II, John Harker, Graydon Masuda, Norikazu Petrakova, Katarina Zotano, Angel Guerrero Iannotti, Nicholas Rodriguez, Gladys Tassone, Pierfrancesco Wong, Alvin Bryce, Richard Ye, Yining Yao, Bin Martin, Miguel